From CAR T-Cell Therapy to the Impact of Mentorship with Carl June, MD

In this episode of From Bench to Fireside, host John Connolly, PhD, Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (PICI), interviews Carl June, MD, Director of the PICI Center at the University of Pennsylvania. Known as "the Father of CAR T-cell therapy," Dr. June's groundbreaking work led to the first FDA-approved CAR T-cell therapy in 2017, revolutionizing precision medicine. Together, they explore the impact of the PICI Network in breaking barriers to accelerate patient-focused progress, the latest advances in CRISPR and CAR T-cell delivery shaping cellular therapy's future, and Dr. June’s reflections on his legacy, the next generation of scientists, and the importance of collaborative research.

--

From Bench to Fireside™ is a new podcast from the Parker Institute for Cancer Immunotherapy (PICI) that tak ...